Celularity Inc. (NASDAQ: CELU) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT CELULARITY INC.

Celularity Inc. (NASDAQ: CELU)
Listen to this Section


$0.90
-0.1000 ( -10.10% ) 29.1K

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.

Clinical Trial Pipeline Stages


Drug Name Stage
PDA-002DetailsFacioscapulohumeral muscular dystrophy Phase 1/2

Market Data


Open $0.90
Previous Close $1.00
Volume 29.1K
Market Cap $29.52M
Day Range $0.89 - $1.03
52 Week Range $0.71 - $4.35
Shares Outstanding 28.95M
Change % -10.10%
Net Change ▼ -0.1000
Insider Ownership -0.02%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2021
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: 16,680,829.00

Date Type Amount Purchased Purchaser
2024-04-16 Sale -20.00 Fletcher Kyle
2024-04-16 Sale -360.00 Beers David C
2024-04-16 Sale -268.00 Brigido Stephen
2024-04-16 Sale -1154.00 Hariri Robert J
2024-04-16 Sale -576.00 Haines John R
2024-03-19 Sale -617.00 Fletcher Kyle
2024-03-15 Sale -300000.00 Lim Kok Thay
2024-02-21 Sale -52762.00 Kilcoyne Adrian
2024-02-21 Sale -32720.00 Brigido Stephen
2024-02-21 Sale -39571.00 Fletcher Kyle

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Dec 30, 2025
8-k 8K-related 25 Dec 23, 2025
4 Insider transactions 1 Dec 22, 2025
4 Insider transactions 1 Dec 22, 2025
4 Insider transactions 1 Dec 22, 2025
s-1 Registration statements 19 Dec 19, 2025
8-k 8K-related 13 Dec 19, 2025
8-k 8K-related 13 Dec 05, 2025
4 Insider transactions 1 Nov 21, 2025
4 Insider transactions 1 Nov 21, 2025

Latest News


× Before browsing our site, please accept our cookies policy